NMOSD Unveiled: Optimizing Long-Term Outcomes in Neuromyelitis Optica Spectrum Disorder with Innovative Therapies

NMOSD Unveiled: Optimizing Long-Term Outcomes in Neuromyelitis Optica Spectrum Disorder with Innovative Therapies

Neuromyelitis optica spectrum disorder (NMOSD) is a relatively new term for a group of rare, demyelinating autoimmune diseases affecting the central nervous system (CNS), particularly the optic nerves and spinal cord. In the past, NMOSD was conflated with multiple sclerosis (MS) due to significant similarities in early-stage presentation. However, recent evidence has shown NMOSD to be a unique disorder with an antibody-mediated etiology distinct from MS. Without proper diagnosis and treatment, patients with NMOSD are likely to develop significant and progressive disability with each recurrent attack. Due to the relatively recent recognition of NMOSD as a distinct diagnostic entity, health care practitioners (HCPs) may lack knowledge and familiarity in its optimal diagnosis and management. It is essential that HCPs understand the etiology and pathophysiology of NMOSD, how novel therapies work to prevent NMOSD attacks, and long-term management strategies that can be utilized in clinical practice. In this CME Outfitters enduring material, expert faculty will discuss strategies to better identify the pathological hallmarks of NMOSD, evaluate diagnostic criteria, utilize established and emerging therapeutics, and implement ongoing care of patients with NMOSD.

  • Provider:CME Outfitters, LLC
  • Activity Link: https://www.cmeoutfitters.com/activity/nmosd-unveiled-optimizing-long-term-outcomes-in-neuromyelitis-optica-spectrum-disorder-with-innovative-therapies-3/
  • Start Date: 2024-06-05 05:00:00
  • End Date: 2024-06-05 05:00:00
  • Credit Details: IPCE Credits: 1.5 hours
    AAPA Category 1 Credit™️: 1.5 hours
    AMA PRA Category 1 Credit™️: 1.5 hours
    Nursing: 1.5 hours
    Pharmacy: 1.5 hours
  • MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Alexion Pharmaceuticals - Amount: 0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Internal Medicine
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.